FI Group UK

ABOUT FI GROUP – GLOBAL REACH, LOCAL EXPERTISE IN LIFE SCIENCES FUNDING

Who We Are

FI Group is a global consultancy dedicated exclusively to innovation funding. With a presence in over 20 countries and more than 18,000 clients worldwide, we support ambitious organisations across the biotech, pharma, and life sciences ecosystem to secure and optimise access to R&D tax relief and grant funding.

Scientific and Sector-Specific Expertise

Our UK team includes PhD-qualified consultants and technical experts with deep scientific backgrounds in:

• Molecular biology
• Drug discovery and development
• Biomedical engineering
• Diagnostics and medical devices

This expertise allows us to bridge the gap between scientific innovation and the expectations of HMRC and public funding bodies.

Tailored Support Across the Innovation Lifecycle

We work directly with CFOs, grant managers, and scientific leadership teams to identify and substantiate qualifying activities across:

• Translational research
• Pre-clinical development
• Clinical trials

We also advise on grant applications to schemes such as:

• Biomedical Catalyst
• Innovate UK Smart
• EIC Accelerator
• EU and Horizon Europe funding programmes

Built for the Challenges of Life Sciences Growth

FI Group understands the specific financial and operational challenges facing life sciences companies, including:

• Long development timelines and high scientific risk
• Cashflow sensitivity and capital intensity
• Complex alignment of IP strategy, funding, and investor milestones

We tailor our support to ensure funding strategy is fully aligned with your commercial and scientific objectives.

Your Partner in Innovation Funding

We speak both the language of science and the language of funding. With FI Group as your partner, you gain more than a funding advisor — you gain a strategic team committed to transforming your innovation into fundable, compliant, and impactful outcomes.